Nutex Health Inc

For the period ended Dec 31, 2023. Filed Mar 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 29, 2024

NUTX$194.16+7.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Equity (Deficit)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY


· · Common Stock · · Additional Paid-in · · Retained Earnings · · Noncontrolling · · Total
· Shares · Amount · Capital · (Accumulated Deficit) · Interests · Equity

Balance at January 1, 2021	592,791,712	592,792	$9,724,053	$81,413,211	$55,638,769	$147,368,825
Contributions	-	-	2,018,838	-	19,734,935	21,753,773
Distributions	-	-	-	(111,690,916)	(32,647,007)	(144,337,923)
Deconsolidation of Kyle Assets, LLC	-	-	-	-	(1,728,950)	(1,728,950)
Net income	-	-	-	132,593,328	35,931,957	168,525,285
Balance at December 31, 2021	592,791,712	592,792	$11,742,891	$102,315,623	$76,929,704	$191,581,010
Reverse acquisition with Clinigence	50,961,109	50,961	436,449,305	-	194,747	436,695,013
Deconsolidation of Real Estate Entities	-	-	-	(6,466,946)	(32,336,946)	(38,803,892)
Notes payable converted to common stock	3,474,430	3,475	5,381,897	-	-	5,385,372
Common stock issued for exercise of warrants	2,147,252	2,147	4,116,994	-	-	4,119,141
Common stock issued for exercise of options	312,019	312	644,662	-	-	644,974
Rescission of warrant exercise	(819,000)	(819)	(25,572)	-	-	(26,391)
Equity financing agreement Lincoln Park Capital Fund, LLC	1,356,318	1,356	(1,356)	-	-	-
Stock-based compensation	-	-	189,581	-	-	189,581
Contributions	-	-	-	-	4,513,867	4,513,867
Distributions	-	-	-	(34,354,156)	(16,877,501)	(51,231,657)
Net loss	-	-	-	(424,780,446)	(7,959,172)	(432,739,618)
Balance at December 31, 2022	650,223,840	$650,224	$458,498,402	$(363,285,925)	$24,464,699	$120,327,400
Deconsolidation of Real Estate Entities	-	-	-	-	(4,258,133)	(4,258,133)
Common stock issued for exercise of warrants	1,268,327	1,268	(1,268)	-	-	-
Common stock issued to Apollo Medical Holding Inc.	1,000,000	1,000	1,899,000	-	-	1,900,000
Common stock issued for Employee Stock Purchase Plan	77,242	77	14,211	-	-	14,288
Common stock issued for acquisition	2,541,511	2,542	902,692	-	-	905,234
Debt conversion to common stock	21,357,603	21,358	6,196,379	-	-	6,217,737
Stock-based compensation	211,388	211	935,756	-	-	935,967
Warrants issued with convertible debt	-	-	1,403,877	-	-	1,403,877
Contributions	-	-	-	-	298,032	298,032
Distributions	-	-	-	-	(5,214,581)	(5,214,581)
Net income (loss)	-	-	-	(45,786,614)	2,362,899	(43,423,715)
Balance at December 31, 2023	676,679,911	$676,680	$469,849,049	$(409,072,539)	$17,652,916	$79,106,106

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.